drugset / Trial / NCT01739244

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

NCT01739244

Phase 2 Completed 80 enrolled Sylentis, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this dose-finding clinical trial is to evaluate the systemic tolerability, local tolerability and intraocular pressure lowering effect of three different doses of SYL040012 in subjects with ocular hypertension or open-angle glaucoma.

Timeline

Start
2012-07
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject bamosiran Unknown Topical